The American Heart Association and American College of Cardiology have released updated 2026 cholesterol guidelines focusing on early management of LDL and triglycerides. The recommendations emphasize personalized treatment, earlier use of lipid-lowering drugs if lifestyle changes fail, new PREVENT-ASCVD risk assessment, and screening for biomarkers like Lp(a) to better prevent heart disease.